Recall of ETES Gentamicin GM256

According to New Zealand Medicines and Medical Devices Safety Authority, this recall involved a device in New Zealand that was produced by Biomerieux SA.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    21232
  • Event Initiated Date
    2017-03-17
  • Event Country
  • Event Source
    NZMMDSA
  • Event Source URL
  • Notes / Alerts
    Data from New Zealand is current through July 2018. All of the data comes from the New Zealand Medicines and Medical Devices Safety Authority, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and New Zealand.
  • Extra notes in the data
    Recalling Organisation: Medi'Ray New Zealand Ltd, 53-55 Paul Matthews Road, Albany, Auckland 0632
  • Reason
    The manufacturer has observed that current shelf-life claims of the etest® gentamicin gm256 product are not supported by internal testing. no increase of the complaint trend was observed for these products, but the manufacturer is taking the precaution of revising the shelf-life claims, that requires your immediate attention to ensure proper use of the product within its revised shelf-life of forty-eight (48) months.
  • Action
    Product to be destroyed

Device

  • Model / Serial
    Model: , Affected: ETES Gentamicin GM256 (Ref. 512518) FOAM packaging
  • Manufacturer

Manufacturer